费诺纤维酸的长期使用作为初级胆道胆道炎的二线治疗:一项回顾性研究
Mariko Maxwell1, Yanhong Deng2, Bonnie Chen1
1Section of Digestive Diseases and Liver Center, Yale School of Medicine, New Haven, Connecticut, USA.
Alimentary pharmacology & therapeutics
|February 18, 2026
概括
芬诺纤维酸为初级胆道胆炎 (PBC) 患者提供安全有效的二线治疗,这些患者对乌尔索多基醇酸 (UDCA) 反应不佳. 这项研究表明,纤维酸改善胆固醇标志物和预后得分,使其成为一个具有成本效益的选择.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 原发性胆道胆道炎 (PBC) 常常表现出对乌尔索氧胆酸 (UDCA) 的不完全反应.
- 费诺纤维酸,一个PPAR-α激动剂,是潜在的二线治疗PBC.
- 关于费诺纤维酸在PBC中的疗效的纵向数据有限.
研究的目的:
- 评估芬诺纤维酸对PBC患者胆固醇生物标志物,预后得分和纤维化指数的长期影响.
- 评估费诺纤维酸作为其他PPAR激动剂的成本效益和可访问的替代品.
主要方法:
- 一个单一中心的回顾性队列研究,包括59名用芬诺纤维酸治疗的PBC患者 (2012-2024年).
- 性酸酶 (ALP) 正常化的分析,GLOBE,英国-PBC和FIB-4分数.
- 评估纤维酸的耐受性和停止治疗的原因.
主要成果:
- 总体而言,ALP正常化的中位时间为9.5个月,而那些不符合巴黎II标准的治疗前患者则为11.2个月.
- 观察到GLOBE预后得分的显著改善.
- 英国-PBC分数和FIB-4纤维化指数保持稳定.
- 费诺纤维酸盐耐受性良好,仅有5%的患者因肝酶升高而停止服用.
结论:
- 费诺纤维酸可显著改善胆固醇标志物和预后结血病患者的预后结血病得分,这些患者的UDCA反应不足.
- 费诺纤维酸盐表现出一个有利的安全性.
- 费诺纤维酸是一种可行的,可访问的,负担得起的二线治疗PBC.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
393
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
393
Ultrasound II: Endoscopic Ultrasound and FibroScan
805
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
805
Chronic Bowel Disorders: Introduction
820
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
820
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
259
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
259
Chronic Pancreatitis I: Introduction
762
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
762


